Skip to main content
. Author manuscript; available in PMC: 2020 Sep 15.
Published in final edited form as: Am J Gastroenterol. 2020 Feb;115(2):224–233. doi: 10.14309/ajg.0000000000000474

Table 1.

Patient characteristics

Non-EoE control (N = 35) HI EoE (N = 93) Pa
Demographics (n, %)
 Age (mean ± SD) 10.9 ± 4.2 9.7 ± 4.4 0.40
 Male 18 (51.4) 66 (71) 0.06
 White 31 (88.6) 86 (92.5) 0.49
 Hispanic 6 (17.1) 9 (9.7) 0.35
Comorbidities (n, %)
 Asthma 8 (22.9) 40 (43) 0.042
 Eczema 12 (34.2) 38 (40.9) 0.55
 Allergic rhinitis 16 (45.7) 53 (57) 0.32
 Food allergy 4 (11.4) 30 (32.3) 0.024
 GERD 6 (17.1) 20 (21.5) 0.81
Visual findings (n, %)
 Edema 0 23 (24.7) <0.001
 Exudate 0 12 (12.9) 0.036
 Furrows 0 28 (30.1) <0.001
 Rings 0 19 (20.4) 0.002
 Stricture 0 0 ND
Peak cells/hpf (mean ± SD)
 Mast cell 7.6 ± 5.7 16.7 ± 11.3 <0.001
 Degranulated mast cell 3.2 ± 3.6 6.7 ± 5.4 <0.001
 Eosinophil 1.4 ± 3.3 3.4 ± 3.9 0.001
Histologic scoring (mean ± SD)
 Epithelial score 0.6 ± 1.6 2.2 ± 2.2 <0.001
 Eosinophilia score 0 ± 0 0.7 ± 0.7 <0.001
a

Categorical variables compared with the Fisher exact test; continuous variables compared with unpaired 2-sample t-test.

EoE, eosinophilic esophagitis; GERD, gastroesophageal reflux disease; HI, histologically inactive; ND, not determined.